Literature DB >> 22451937

Transport of drugs by the multidrug transporter AcrB involves an access and a deep binding pocket that are separated by a switch-loop.

Thomas Eicher1, Hi-jea Cha, Markus A Seeger, Lorenz Brandstätter, Jasmin El-Delik, Jürgen A Bohnert, Winfried V Kern, François Verrey, Markus G Grütter, Kay Diederichs, Klaas M Pos.   

Abstract

AcrAB-TolC is the major efflux protein complex in Escherichia coli extruding a vast variety of antimicrobial agents from the cell. The inner membrane component AcrB is a homotrimer, and it has been postulated that the monomers cycle consecutively through three conformational stages designated loose (L), tight (T), and open (O) in a concerted fashion. Binding of drugs has been shown at a periplasmic deep binding pocket in the T conformation. The initial drug-binding step and transport toward this drug-binding site has been elusive thus far. Here we report high resolution structures (1.9-2.25 Å) of AcrB/designed ankyrin repeat protein (DARPin) complexes with bound minocycline or doxorubicin. In the AcrB/doxorubicin cocrystal structure, binding of three doxorubicin molecules is apparent, with one doxorubicin molecule bound in the deep binding pocket of the T monomer and two doxorubicin molecules in a stacked sandwich arrangement in an access pocket at the lateral periplasmic cleft of the L monomer. This access pocket is separated from the deep binding pocket apparent in the T monomer by a switch-loop. The localization and conformational flexibility of this loop seems to be important for large substrates, because a G616N AcrB variant deficient in macrolide transport exhibits an altered conformation within this loop region. Transport seems to be a stepwise process of initial drug uptake in the access pocket of the L monomer and subsequent accommodation of the drug in the deep binding pocket during the L to T transition to the internal deep binding pocket of the T monomer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22451937      PMCID: PMC3326505          DOI: 10.1073/pnas.1114944109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Crystal structure of bacterial multidrug efflux transporter AcrB.

Authors:  Satoshi Murakami; Ryosuke Nakashima; Eiki Yamashita; Akihito Yamaguchi
Journal:  Nature       Date:  2002-10-10       Impact factor: 49.962

2.  Structural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump.

Authors:  Edward W Yu; Gerry McDermott; Helen I Zgurskaya; Hiroshi Nikaido; Daniel E Koshland
Journal:  Science       Date:  2003-05-09       Impact factor: 47.728

3.  Site-directed disulfide cross-linking shows that cleft flexibility in the periplasmic domain is needed for the multidrug efflux pump AcrB of Escherichia coli.

Authors:  Yumiko Takatsuka; Hiroshi Nikaido
Journal:  J Bacteriol       Date:  2007-09-28       Impact factor: 3.490

4.  Vestibules are part of the substrate path in the multidrug efflux transporter AcrB of Escherichia coli.

Authors:  Fasahath Husain; Mihir Bikhchandani; Hiroshi Nikaido
Journal:  J Bacteriol       Date:  2011-08-19       Impact factor: 3.490

5.  A periplasmic drug-binding site of the AcrB multidrug efflux pump: a crystallographic and site-directed mutagenesis study.

Authors:  Edward W Yu; Julio R Aires; Gerry McDermott; Hiroshi Nikaido
Journal:  J Bacteriol       Date:  2005-10       Impact factor: 3.490

Review 6.  Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels.

Authors:  B Miroux; J E Walker
Journal:  J Mol Biol       Date:  1996-07-19       Impact factor: 5.469

7.  Integration, scaling, space-group assignment and post-refinement.

Authors:  Wolfgang Kabsch
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

Review 8.  The AcrB efflux pump: conformational cycling and peristalsis lead to multidrug resistance.

Authors:  Markus A Seeger; Kay Diederichs; Thomas Eicher; Lorenz Brandstätter; André Schiefner; François Verrey; Klaas M Pos
Journal:  Curr Drug Targets       Date:  2008-09       Impact factor: 3.465

9.  Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli.

Authors:  D Ma; D N Cook; M Alberti; N G Pon; H Nikaido; J E Hearst
Journal:  Mol Microbiol       Date:  1995-04       Impact factor: 3.501

Review 10.  Mechanisms of RND multidrug efflux pumps.

Authors:  Hiroshi Nikaido; Yumiko Takatsuka
Journal:  Biochim Biophys Acta       Date:  2008-11-03
View more
  117 in total

1.  Coarse-grained simulations of conformational changes in the multidrug efflux transporter AcrB.

Authors:  Yead Jewel; Jin Liu; Prashanta Dutta
Journal:  Mol Biosyst       Date:  2017-09-26

2.  AcrB-AcrA Fusion Proteins That Act as Multidrug Efflux Transporters.

Authors:  Katsuhiko Hayashi; Ryosuke Nakashima; Keisuke Sakurai; Kimie Kitagawa; Seiji Yamasaki; Kunihiko Nishino; Akihito Yamaguchi
Journal:  J Bacteriol       Date:  2015-11-02       Impact factor: 3.490

3.  Reversal of the Drug Binding Pocket Defects of the AcrB Multidrug Efflux Pump Protein of Escherichia coli.

Authors:  Ketaki Soparkar; Alfred D Kinana; Jon W Weeks; Keith D Morrison; Hiroshi Nikaido; Rajeev Misra
Journal:  J Bacteriol       Date:  2015-08-03       Impact factor: 3.490

Review 4.  Nanobodies as Probes for Protein Dynamics in Vitro and in Cells.

Authors:  Oleg Y Dmitriev; Svetlana Lutsenko; Serge Muyldermans
Journal:  J Biol Chem       Date:  2015-12-16       Impact factor: 5.157

Review 5.  Heavy metal transport by the CusCFBA efflux system.

Authors:  Jared A Delmar; Chih-Chia Su; Edward W Yu
Journal:  Protein Sci       Date:  2015-08-24       Impact factor: 6.725

6.  An embedded lipid in the multidrug transporter LmrP suggests a mechanism for polyspecificity.

Authors:  Vincent Debruycker; Andrew Hutchin; Matthieu Masureel; Emel Ficici; Chloé Martens; Pierre Legrand; Richard A Stein; Hassane S Mchaourab; José D Faraldo-Gómez; Han Remaut; Cédric Govaerts
Journal:  Nat Struct Mol Biol       Date:  2020-07-27       Impact factor: 15.369

7.  Conserved small protein associates with the multidrug efflux pump AcrB and differentially affects antibiotic resistance.

Authors:  Errett C Hobbs; Xuefeng Yin; Brian J Paul; Jillian L Astarita; Gisela Storz
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-24       Impact factor: 11.205

8.  Some ligands enhance the efflux of other ligands by the Escherichia coli multidrug pump AcrB.

Authors:  Alfred D Kinana; Attilio V Vargiu; Hiroshi Nikaido
Journal:  Biochemistry       Date:  2013-11-11       Impact factor: 3.162

9.  β-Lactam selectivity of multidrug transporters AcrB and AcrD resides in the proximal binding pocket.

Authors:  Naoki Kobayashi; Norihisa Tamura; Hendrik W van Veen; Akihito Yamaguchi; Satoshi Murakami
Journal:  J Biol Chem       Date:  2014-02-20       Impact factor: 5.157

10.  Diphenylether-Modified 1,2-Diamines with Improved Drug Properties for Development against Mycobacterium tuberculosis.

Authors:  Marie H Foss; Sovitj Pou; Patrick M Davidson; Jennifer L Dunaj; Rolf W Winter; Sovijja Pou; Meredith H Licon; Julia K Doh; Yuexin Li; Jane X Kelly; Rozalia A Dodean; Dennis R Koop; Michael K Riscoe; Georgiana E Purdy
Journal:  ACS Infect Dis       Date:  2016-05-13       Impact factor: 5.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.